Analyst coverage and ratings

Last data input: Dec 3, 2024

Email: alenze@alantraequities.com

Tel: +34 91 550 8714

Last target price: 10.28 EUR

Last rating input: 31/07/2024

Spain

Neutral

Email: a.raval@alphavalue.eu

Tel: +33 1 7061 1050

Sectors: pharma

Regions: Europe

Last target price: 18.70 EUR

Last rating input: 08/11/2024

France

Buy

Luis Arredondo Sánchez-Cendal

Email: arredondol@bancsabadell.com

Tel: +34 91 321 7257

Last target price: 16.50 EUR

Last rating input: 02/12/2024

Spain

Overweight

Bank of America

Email: graham.parry@bofa.com

Tel: +44 20 7996 0735

Last target price: 16.00 EUR

Last rating input: 03/12/2024

UK

Buy

Pedro Echeguren Ybarra

Email: pecheguren@bankinter.com

Tel: +34 91 794 1031

Sectors: pharma and health

Last rating input: 24/10/2024

Spain

Sell

Barclays Capital

Email: charles.pitman@barclays.com

Tel: +44 20 3134 6023

Sectors: pharmaceuticals

Regions: Europe

Last target price: 14.00 EUR

Last rating input: 27/11/2024

UK

Overweight

Email: tom.jones@berenberg.de

Tel: +44 20 3207 7877

Sectors: med tech, med services

UK

Not public

Email: justin.smith@bernsteinsg.com

Tel: +44 20 7762 5899

Sectors: pharmaceuticals and medical technology

Last target price: 22.00 EUR

Last rating input: 03/12/2024

UK

Outperform

Patricia Cifuentes

Email: pcifuentes@bestinver.es

Tel: +34 90 087 8280

Sectors: retail, healthcare, pharma

Regions: Iberia

Last target price: 13.50 EUR

Last rating input: 30/10/2024

Spain

Buy

BNP Paribas Exane

Email: hugo.solvet@uk.bnpparibas.com

Tel: +33 6 9907 1538

Last target price: 24.00 EUR

Last rating input: 20/05/2024

France

Outperform

Guilherme Macedo Sampaio

Email: guilherme.macedo.sampaio@caixabank.com

Tel: +35 122 607 3179

Last target price: 18.70 EUR

Last rating input: 03/12/2024

Portugal

Buy

Email: peter.verdult@citi.com

Tel: +44 20 7986 4164

Last target price: 23.00 EUR

Last rating input: 02/10/2024

UK

Buy

Emmanuel Papadakis

Email: emmanuel.papadakis@db.com

Tel: +44 20 7541 8522

Sectors: pharmaceuticals and biotechnology

Last target price: 10.00 EUR

Last rating input: 28/11/2024

UK

Hold

Email: atencioncliente@gvcgaesco.es

Tel: +34 93 2712 000

Last target price: 15.75 EUR

Last rating input: 25/11/2024

Spain

Accumulate

Invest Securities

Thibaut Voglimacci-Stephanopoli

Email: tvoglimacci@invest-securities.com

Tel: +33 1 4488 7795

Sectors: medtechs, biotechs

Last target price: 14.00 EUR

Last rating input: 28/11/2024

France

Buy

Joaquín García-Quirós

Email: jgarciaquiros@jbcapital.com

Tel: +34 91 794 0516

Last target price: 18.00 EUR

Last rating input: 27/11/2024

Spain

Buy

Email: james.d.gordon@jpmorgan.com

Tel: +44 20 7588 2828

Sectors: pharma and biotech

Regions: Europe

Last target price: 14.00 EUR

Last rating input: 08/11/2024

UK

Neutral

Kepler Cheuvreux

Pablo de Renteria

Email: prenteria@keplercheuvreux.com

Tel: +34 91 436 5221

Covered Grifols, S.A. since: 2023

Spain

Not rated

Email: joseramon.ocina@mirabaud-msl.com

Tel: +34 91 701 5720

Sectors: telecoms, infrastructure, pharma

Regions: Iberia

Spain

To see rating please choose longer timeperiod

-

Thibault Boutherin

Email: thibault.boutherin@morganstanley.com

Tel: +44 20 7425 9688

UK

Not rated

Email: karen.andersen@morningstar.com

Tel: +1 312 384 4826

United States

Not rated

Juan Ros-Padilla

Email: juan.ros-padilla@oddo-bhf.com

Tel: +34 91 737 0360

Last target price: 9.00 EUR

Last rating input: 19/06/2024

Spain

Underperform

Álvaro Arístegui Echevarria

Email: aaristegui@renta4.es

Tel: +34 91 384 8587

Spain

Not rated

Jaime Escribano

Email: jaime.escribano@gruposantander.com

Tel: +34 91 257 4126

Sectors: small and mid caps

Regions: Iberia

Last target price: 27.00 EUR

Last rating input: 29/11/2024

Spain

Outperform

Recalculate data above, show ratings not older than:
14 days 1 month 3 months 6 months 1 year
or select date here:
or select date here:

Disclaimer

Download

Download page in PDF format

Download data in Excel format

Grifols, S.A. (hereafter referred to as "The Company") is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding The Company's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of The Company or its management. The Company does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Read more...

The information on these web pages does not represent opinions, forecasts or predictions of The Company nor its management. The Company has no control over the content, quality, nature or reliability of any such third party web pages, and shall have no liability whatsoever in respect to the information provided on these web pages. A link to a third party web page does not imply any endorsement, investigation or verification by The Company of any information contained on this web page, and the information is not intended to imply any endorsement of or provide any investment advice.

Eurolandcom AB does not represent or warrant that any information anywhere on these web pages is accurate or complete and it should not be relied upon as such. The information on these web pages is provided for informational purposes only. Any information on these web pages is of an indicative nature and does not, and is not intended to, constitute an offer, solicitation, invitation or recommendation to buy, sell or deliver (directly or indirectly) any securities or derivatives thereon, nor a representation that a purchase or sale thereof can be effected on the basis of such information or at any given price. The information on these web pages does not give rise to any legally binding obligation and/or agreement, including without limitation any obligation to update such information. It may not be reproduced, distributed or published in connection with any offer, solicitation, invitation or recommendation to subscribe for or to buy or sell any securities or derivatives thereon by any recipient. Each recipient shall be deemed to have made its own investigation and appraisal of the financial status of the companies in question. No liability whatsoever is accepted for any direct or consequential loss, expense or damage arising from or in connection with the use of the information on these web pages, including the data stated therein. Nor can this information be interpreted as advice for a particular investment strategy or for any other purpose.

Supplied by © Euroland.com